about
TRAIL-based therapy in pediatric bone tumors: how to overcome resistance.TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical modelsSHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngiomaGalactose-modified duocarmycin prodrugs as senolyticsThe Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic AstrocytomaCardiac glycosides are broad-spectrum senolyticsCRAN-17. TUMOUR COMPARTMENT TRANSCRIPTOMICS DEMONSTRATE THE ACTIVATION OF INFLAMMATORY AND ODONTOGENIC PROGRAMMES IN HUMAN ADAMANTINOMATOUS CRANIOPHARYNGIOMA AND IDENTIFY NOVEL THERAPEUTIC TARGETS
P50
Q38352891-A5CD8858-51D8-4172-AB02-8B7E58CF5C5EQ38750240-B5A710CE-23D4-42FE-852B-143DAD93F75AQ52354928-ABE16C91-401C-46F2-ADF9-336291B436ECQ61978391-BCE2C46A-87F1-4549-8C0E-1ECC91E2976DQ64249647-A81C5820-AB84-4E21-B283-684A238C4126Q90350293-CACC13FA-97C8-47B8-9102-51AEEDAE0070Q90365196-86F9DD84-6E8C-4E62-9019-288402AEDC57Q91677826-0F5B00C1-8407-411C-B57C-DFC846D6C399Q94065159-C4D5F09F-D768-41EB-AB1E-F079EE769152
P50
description
researcher
@en
name
Romain Guiho
@en
type
label
Romain Guiho
@en
prefLabel
Romain Guiho
@en
P31
P496
0000-0002-9231-6445